Font: Financial Modeling Prep • Aug 04, 2025
Freshpet (NASDAQ:FRPT) posted second-quarter results that exceeded earnings expectations, lifting shares over 6% today, despite missing revenue forecasts and trimming its sales guidance.
The company reported adjusted earnings per share of $0.33, well ahead of the $0.11 consensus. Revenue rose 12.5% year-over-year to $264.7 million, falling short of the $267.85 million forecast. Growth was driven by a 10.8% increase in volume and a 1.7% favorable price/mix.
Freshpet posted net income of $16.4 million versus a loss of $1.7 million a year ago. Gross margin improved to 40.9%, up from 39.9%, while adjusted EBITDA rose to $44.4 million from $35.1 million in the same period last year.
Freshpet lowered its 2025 net sales growth forecast to 13–16%, down from 15–18%, citing consumer economic pressures. However, it maintained its adjusted EBITDA target of $190–$210 million and reduced its capital spending outlook to $175 million from $225 million.
The company also withdrew its long-term $1.8 billion sales target for 2027 but reaffirmed its adjusted gross margin goal of 48% and EBITDA margin target of 22%.
|
SOXS§>
Direxion Daily Semiconductor Bear 3X Shares
|
$1.66
-4.60%
|
|
BHAT§>
Fujian Blue Hat Interactive Entertainment Technology Ltd.
|
$0.07
6.84%
|
|
EZRA§>
Reliance Global Group Inc.
|
$0.29
11.37%
|
|
BRTX§>
BioRestorative Therapies, Inc.
|
$0.27
37.01%
|
|
NVDA§>
NVIDIA Corporation
|
$192.85
0.68%
|
|
ZSL§>
ProShares UltraShort Silver
|
$1.88
3.87%
|
|
TLIH§>
Ten-League International Holdings Limited Ordinary Shares
|
$0.44
37.74%
|
|
TZA§>
Direxion Daily Small Cap Bear 3X Shares
|
$6.09
-3.33%
|
|
INTC§>
Intel Corporation
|
$46.12
5.71%
|
|
EDSA§>
Edesa Biotech, Inc.
|
$1.51
67.96%
|